Cover [Abstract] Document Type Document Type Document Quarterly Report Document Period End Date Document Period End Date Document Transition Report Document Transition Report Entity File Number Entity File Number Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address Address Line1 Entity Address, Address Line One Entity Address Address Line2 Entity Address, Address Line Two Entity Address City Or Town Entity Address, City or Town Entity Address State Or Province Entity Address, State or Province Entity Address Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Security12b Title Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Shell Company Entity Shell Company Entity Common Stock Shares Outstanding Entity Common Stock, Shares Outstanding Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Statement of Financial Position [Abstract] Statement [Table] Statement [Table] Statement [Line Items] Statement [Line Items] Assets [Abstract] Assets Assets Current [Abstract] Current assets: Cash And Cash Equivalents At Carrying Value Cash and cash equivalents Marketable Securities, Current Investments in marketable securities Receivables, Net, Current Trade receivables, net Amount of transition services agreement receivable current. Transition Services Agreement Receivable Current TSA receivables, net (Note 6) TSA receivables, net Inventory Net Inventory Prepaid Manufacturing current. Prepaid Manufacturing Expense Current Prepaid manufacturing Prepayment made for manufacturing services Prepaid Expense And Other Assets Current Other prepaids and current assets Assets Current Total current assets Property, Plant and Equipment, Net Property and equipment, net Inventory Noncurrent Inventory, non-current Intangible Assets, Net (Including Goodwill) Intangible assets, net Total Intangible assets, net Other Assets Noncurrent Other assets, non-current Assets Total assets Liabilities And Stockholders Equity [Abstract] Liabilities and Stockholders' Deficit Liabilities Current [Abstract] Current liabilities: Accounts Payable Current Accounts payable Accrued rebates, fees and reserve. Accrued Rebates Fees And Reserve Current Accrued rebates, fees and reserves Amount of transition services agreement payables classified as current. Transition Services Agreement Payables and Other Accrued Liabilities Current TSA payables and other accrued liabilities (Note 6) TSA payables and other accrued liabilities Employee Related Liabilities Current Accrued compensation Accrued Liabilities Current Accrued and other current liabilities Total Accrued and other current liabilities Liabilities Current Total current liabilities Carrying value as of the balance sheet date of term loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. Term Loans Payable, Noncurrent Term loans, non-current Convertible Subordinated Debt, Noncurrent Convertible notes Present value of lessee's discounted obligation for lease payments from operating and finance lease, classified as noncurrent. Operating and Finance Lease, Liability, Noncurrent Lease liabilities, non-current Other Liabilities Noncurrent Other liabilities, non-current Total Other liabilities, non-current Liabilities Total liabilities Commitments And Contingencies Commitments and contingencies (Note 9) Stockholders Equity Including Portion Attributable To Noncontrolling Interest [Abstract] Stockholders' deficit: Common Stock Value Common stock ($0.0001 par value; shares authorized: 300,000,000; shares issued and outstanding: 115,198,655 and 112,215,260 at June 30, 2024 and December 31, 2023, respectively) Additional Paid In Capital Common Stock Additional paid-in capital Accumulated Other Comprehensive Income Loss Net Of Tax Accumulated other comprehensive loss Retained Earnings Accumulated Deficit Accumulated deficit Stockholders Equity Including Portion Attributable To Noncontrolling Interest Ending Balances Beginning Balances Total stockholders' deficit Liabilities And Stockholders Equity Total liabilities and stockholders' deficit Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Common Stock Par Or Stated Value Per Share Common stock, par value Common Stock Shares Authorized Common stock, shares authorized Common Stock Shares Issued Common stock, shares issued Common Stock Shares Outstanding Ending Balances (in shares) Beginning Balances (in shares) Common stock, shares outstanding Income Statement [Abstract] Revenues [Abstract] Revenue: Revenue From Contract With Customer Including Assessed Tax Net revenue Operating Expenses [Abstract] Costs and expenses: Cost Of Sold Goods Cost of goods sold Research And Development Expense Research and development Research and development Selling General And Administrative Expense Selling, general and administrative Operating Expenses Total costs and expenses Operating Income Loss Loss from operations Interest Expense Interest expense Gain (Loss) on Sale of Interest in Projects Gain on Sale Transaction, net (Note 6) Gain on Sale Transaction, net (Note 6) Gain (Loss) on Extinguishment of Debt Loss on debt extinguishment Loss on debt extinguishment Other Nonoperating Income Expense Other income (expense), net Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest Pretax profit (loss) Income (loss) before income taxes Net income (loss) Net income (loss) Net Income (Loss) Per Share Net income (loss) per share: Earnings Per Share Basic Basic net income (loss) per share Basic (In dollar per share) Earnings Per Share Diluted Diluted net income (loss) per share Diluted (In dollar per share) Weighted Average Number Of Shares Outstanding [Abstract] Weighted-average number of shares used in computing net income (loss) per share: Denominator: Weighted Average Number Of Shares Outstanding Basic Basic (In shares) Weighted-average common shares outstanding - Basic Weighted-average common shares outstanding - Diluted Diluted (In shares) Weighted-average common shares outstanding - Diluted Statement of Comprehensive Income [Abstract] Profit Loss Net income (loss) Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract] Other comprehensive income (loss): Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax Unrealized loss on available-for-sale securities, net of tax Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Foreign currency translation adjustments, net of tax Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest Comprehensive income (loss) Statement of Stockholders' Equity [Abstract] Statement Equity Components [Axis] Equity Component Common Stock Additional Paid-In Capital Accumulated Other Comprehensive Loss Accumulated Deficit Subsidiary Sale Of Stock [Axis] Sale of Stock Represents information relating to at the market offering issuance. At The Market Offering. Represents information pertaining to public offering. Public Offering Stock Issued During Period Value Stock Options Exercised Issuance of common stock upon exercise of stock options Stock Issued During Period Shares Stock Options Exercised Issuance of common stock upon exercise of stock options (in shares) Stock Issued During Period, Value, Restricted Stock Award, Gross Issuance of common stock upon vesting of restricted stock units ("RSUs") Stock Issued During Period, Shares, Restricted Stock Award, Gross Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares) Value of stock issued during period in lieu of bonus. Stock Issued During Period, Partial Payout, Bonus Issuance of common stock - partial payout of 2023 bonus in RSUs Number of shares issued in lieu of bonus. Stock Issued During Period, Partial Payout, Bonus, Shares Issuance of common stock - partial payout of 2023 bonus in RSUs (in shares) Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Stock-based compensation expense Stock Issued During Period, Value, New Issues Issuance of common stock under Offering, net of issuance costs Stock Issued During Period, Shares, New Issues Issuance of common stock under Offering, net of issuance costs (in shares) Common stock, shares issued and sold Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Offering costs associated with ATM offering Stock Issued During Period Value Employee Stock Purchase Plan Issuance of common stock under the employee stock purchase plan ("ESPP") Stock Issued During Period Shares Employee Stock Purchase Plans Issuance of common stock under the employee stock purchase plan ("ESPP") (in shares) Adjustments Related To Tax Withholding For Share Based Compensation Taxes paid related to net share settlement of RSUs Shares Paid For Tax Withholding For Share Based Compensation Taxes paid related to net share settlement of RSUs (in shares) Other Comprehensive Income (Loss), Net of Tax Other comprehensive loss, net of tax Statement of Cash Flows [Abstract] Disposal Group Name [Axis] Disposal Group Name [Domain] Represents the information pertaining to CIMERLI ophthalmology franchise. CIMERLI Ophthalmology Franchise [Member] CIMERLI Sale Represents the information pertaining to YUSIMRY immunology franchise. YUSIMRY Immunology Franchise [Member] YUSIMRY Sale Net Cash Provided By Used In Operating Activities [Abstract] Operating activities Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Depreciation And Amortization Depreciation and amortization Share Based Compensation Stock-based compensation expense The amount of Impairment of out-license asset and remeasurement of CVR liability, net. Impairment of Intangible Assets And Contingent Value Rights Liability Impairment of out-license asset and remeasurement of CVR liability, net Net impairment charge Inventory Write Down Inventory write-downs, net Inventory write-downs Other Operating Activities, Cash Flow Statement Other non-cash adjustments, net Increase Decrease In Operating Capital [Abstract] Changes in operating assets and liabilities: Increase Decrease In Receivables Trade receivables, net Increase Decrease In Inventories Inventory Increase Decrease In Prepaid Expense Prepaid manufacturing Increase Decrease In Prepaid Deferred Expense And Other Assets Other prepaid, current and non-current assets Increase Decrease In Accounts Payable Trade Accounts payable Increase decrease in accrued rebates, fees and reserve. Increase Decrease In Accrued Rebates Fees And Reserve Accrued rebates, fees and reserves Increase (Decrease) in Other Operating Assets and Liabilities, Net TSA related operating assets and liabilities, net (Note 6) Increase decrease in accrued compensation. Increase Decrease In Accrued Compensation Accrued compensation Increase Decrease In Accrued Liabilities And Other Operating Liabilities Accrued and other current and non-current liabilities Net Cash Provided By Used In Operating Activities Net cash provided by (used in) operating activities Net Cash Provided By Used In Investing Activities [Abstract] Investing activities Payments to Acquire Marketable Securities Purchases of investments in marketable securities Proceeds From Sale And Maturity Of Marketable Securities Proceeds from maturities of investments in marketable securities Proceeds from Sale of Debt Securities, Available-for-Sale Proceeds from sale of investments in marketable securities Proceeds from Divestiture of Businesses Cash received from Sale The cash outflow associated with milestone based license fee payment. Payments For Milestone Based License Fee Milestone based license fee payment to Junshi Biosciences Payments for (Proceeds from) Other Investing Activities Other investing activities, net Net Cash Provided By Used In Investing Activities Net cash provided by investing activities Net Cash Provided By Used In Financing Activities [Abstract] Financing activities Proceeds from Issuance of Debt Proceeds from 2029 Term Loan, net of debt discount & issuance costs The cash inflow during the period from revenue purchase and sale agreement. Proceeds From Revenue Purchase And Sale Agreement Net Proceeds from Revenue Purchase and Sale Agreement, net of issuance costs Proceeds From Issuance Of Common Stock Proceeds from issuance of common stock, net of issuance costs Proceeds From Stock Options Exercised Proceeds from issuance of common stock upon exercise of stock options Proceeds from Stock Plans Proceeds from purchase under the employee stock purchase plan Payments Related To Tax Withholding For Share Based Compensation Taxes paid related to net share settlement Repayments of Debt Repayment of 2027 Term Loans, premiums and exit fees Outstanding amount paid off Proceeds from (Payments for) Other Financing Activities Other financing activities Net Cash Provided By Used In Financing Activities Net cash (used in) provided by financing activities Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Net increase in cash, cash equivalents and restricted cash Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Cash, cash equivalents and restricted cash at end of period Cash, cash equivalents and restricted cash at beginning of period Total cash, cash equivalents and restricted cash Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract] Supplemental disclosures of non-cash activities Stock Issued Non-cash employee bonuses settled in common stock Future cash outflow to pay for issuance cost of debt. Issuance Cost of Debt Incurred but Not yet Paid Financing issuance costs in accrued and other current liabilities Revenue Revenue From Contract With Customer [Text Block] Revenue Fair Value Measurements Fair Value Disclosures [Text Block] Fair Value Measurements Inventory Inventory Disclosure [Text Block] Inventory Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Balance Sheet Components No definition available. Acquisition and Disposition The disclosure of acquisition and disposal of business. Acquisition and Disposal of Business [Text Block] Acquisition and Disposition Collaboration and license agreements. Collaborations and Other Arrangements Collaborative Arrangement Disclosure [Text Block] Collaborations and Other Arrangements Financial Liabilities Debt Disclosure [Text Block] Financial Liabilities Commitments and Contingencies. Commitments And Contingencies Disclosure [Text Block] Commitments and Contingencies Stockholders' Deficit Disclosure containing information regarding Stockholders' Deficit. Stockholders Deficit Stockholders' Deficit Stock-Based Compensation Disclosure Of Compensation Related Costs Share Based Payments [Text Block] Stock-Based Compensation